Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07823127 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MRX-901: An Open-label Study to Assess Safety and Tolerability of Maralixibat in Participants With Intrahepatic Cholestasis of Pregnancy (ICP)

Study acronym: OASIS
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is designed to assess whether the investigational drug maralixibat, is safe and well tolerated in pregnant women with intrahepatic cholestasis of pregnancy (ICP). This is an open-label study where all participants will receive maralixibat.
Trial Details
NCT Number NCT07823127
Lead Sponsor Mirum Pharmaceuticals, Inc.
Conditions
(from sponsor)		 Intrahepatic Cholestasis of Pregnancy
Related terms Intrahepatic Cholestasis of Pregnancy
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov